4//SEC Filing
Schwab Andrew J. 4
Accession 0001104659-24-108702
CIK 0001736730other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 5:48 PM ET
Size
18.6 KB
Accession
0001104659-24-108702
Insider Transaction Report
Form 4
Schwab Andrew J.
Director10% Owner
Transactions
- Conversion
Common Stock
2024-10-15+302,770→ 302,770 total(indirect: See Footnote) - Conversion
Common Stock
2024-10-15+1,337,592→ 1,337,592 total(indirect: See Footnote) - Conversion
Series B Preferred Stock
2024-10-15−4,244,770→ 0 total(indirect: See Footnote)→ Common Stock (378,463 underlying) - Conversion
Common Stock
2024-10-15+378,463→ 1,716,055 total(indirect: See Footnote) - Purchase
Common Stock
2024-10-15$11.00/sh+909,090$9,999,990→ 2,625,145 total(indirect: See Footnote) - Conversion
Series A Prime Preferred Stock
2024-10-15−15,002,166→ 0 total(indirect: See Footnote)→ Common Stock (1,337,592 underlying) - Conversion
Series B Preferred Stock
2024-10-15−3,395,816→ 0 total(indirect: See Footnote)→ Common Stock (302,770 underlying)
Footnotes (4)
- [F1]On October 15, 2024, the shares of Series A Prime Convertible Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering. The Series A Convertible Preferred Stock had no expiration date.
- [F2]The reported securities are held directly by 5AM Ventures VI, L.P. ("5AM Ventures VI"). 5AM Partners VI, LLC ("Partners VI") is the sole general partner of 5AM Ventures VI. The Reporting Person is a managing member of Partners VI and may be deemed to share voting and investment power over the shares held by 5AM Ventures VI. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
- [F3]On October 15, 2024, the shares of Series B Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date.
- [F4]The reported securities are held by 5AM Opportunities II, L.P. ("5AM Opportunities"). 5AM Opportunities II (GP), LLC ("Opportunities II GP") is the sole general partner of 5AM Opportunities. The Reporting Person is a managing member of Opportunities II GP and may be deemed to share voting and investment power over the shares held by 5AM Opportunities. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
Documents
Issuer
Camp4 Therapeutics Corp
CIK 0001736730
Entity typeother
Related Parties
1- filerCIK 0001598549
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 5:48 PM ET
- Size
- 18.6 KB